Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Arena Pharmaceuticals, Inc. (ARNA)

« Back to company index

ARNA Chatter Timeline

Stock Ticker for ARNA

Most Active Tweeters for ARNA

UserTweets
@Tickeron 14
@Gambiste1 4
@gcassidy718 4
@OpenOutcrier 2
@deus_trader 2

Recent Tweets for ARNA

Tickeron @Tickeron
$ARNA's Aroon indicator reaches into Uptrend on March 27, 2020. View odds for this and other indicators:… https://t.co/uPhBNyzMdh
April 9th 2020, 3:04pm
Tickeron @Tickeron
$ARNA's Aroon indicator reaches into Uptrend on March 27, 2020. View odds for this and other indicators:… https://t.co/ci0R6v6fYQ
April 8th 2020, 11:04am
TalkMarkets @TalkMarkets
Cannabis Central: How Well Do The Two New TSX Cannabis Indexes Track The Industry's Stock Performance? $CGC $ARNA… https://t.co/YLRkn1UQ4k
April 7th 2020, 4:04pm
JMLInvestments @JMLInvestments
RT @SeekingAlpha: $ARNA - Arena Pharmaceuticals (ARNA) Investor Presentation - Slideshow. https://t.co/Elx1VByU04 #business #markets #econo…
April 7th 2020, 4:04pm
SeekingAlpha @SeekingAlpha
$ARNA - Arena Pharmaceuticals (ARNA) Investor Presentation - Slideshow. https://t.co/Elx1VByU04 #business #markets #economy
April 7th 2020, 4:04pm
Tickeron @Tickeron
$ARNA's Aroon indicator reaches into Uptrend on March 27, 2020. View odds for this and other indicators:… https://t.co/J0fRGXSvhO
April 7th 2020, 12:04pm
gcassidy718 @gcassidy718
$ARNA Would say I'm surprised, but I'm not. Will check ER. Might dabble again. Maybe. 4.46 % change recently https://t.co/5RGE4KUZhl
April 6th 2020, 10:04pm
Tickeron @Tickeron
$ARNA's in Uptrend: Moving Average Convergence Divergence (MACD) Histogram just turned positive. View odds for this… https://t.co/Q7S3COMsNv
April 6th 2020, 11:04am
Tickeron @Tickeron
$ARNA's in Uptrend: Moving Average Convergence Divergence (MACD) Histogram crosses above signal line. View odds for… https://t.co/ziYBqCfWtA
April 5th 2020, 11:04am
A1Trades4U @A1Trades4U
$ARNA from https://t.co/RfWl9yJKRP https://t.co/RT169UUS6a #bullish. Notes are in the chart. 20 day almost crossed… https://t.co/dBz9dRNyaX
April 4th 2020, 11:04pm
Tickeron @Tickeron
$ARNA's in Uptrend: Moving Average Convergence Divergence (MACD) Histogram crosses above signal line. View odds for… https://t.co/PPscmceSUq
April 4th 2020, 12:04pm
TranscriptDaily @TranscriptDaily
Arena Pharmaceuticals $ARNA Now Covered by Analysts at Guggenheim https://t.co/9ONNrVQbZK
April 4th 2020, 8:04am
WeekHerald @WeekHerald
Arena Pharmaceuticals $ARNA Now Covered by Analysts at Guggenheim https://t.co/AMCLNm5x4Q
April 4th 2020, 8:04am
dakotafinancial @dakotafinancial
Arena Pharmaceuticals $ARNA Trading 8% Higher https://t.co/dBpjIniUqX
April 4th 2020, 7:04am
dailypoliticaln @dailypoliticaln
Arena Pharmaceuticals $ARNA Trading 8% Higher https://t.co/Tds4IcfLzl
April 4th 2020, 7:04am
EnterpriseLeade @EnterpriseLeade
Arena Pharmaceuticals $ARNA Trading 8% Higher https://t.co/aBHC1ILel3
April 4th 2020, 7:04am
MarcJacksonLA @MarcJacksonLA
RT @MSollender: JPM 9 biotech picks (2/2): $ARNA - Strong balance sheet, good entry point for a busy 2H20/21 $UTHR - Commercial products…
April 3rd 2020, 9:04pm
SwingTradeBot @SwingTradeBot
Rose Above Upper Bollinger Band today: $ARNA $DNN ... https://t.co/AyIukUGmib
April 3rd 2020, 3:04pm
MSollender @MSollender
JPM 9 biotech picks (2/2): $ARNA - Strong balance sheet, good entry point for a busy 2H20/21 $UTHR - Commercial p… https://t.co/lRhdLXfHtH
April 3rd 2020, 1:04pm
Tickeron @Tickeron
$ARNA enters an Uptrend because Momentum Indicator exceeded the 0 level on March 25, 2020. View odds for this and o… https://t.co/7F8X5ohT9M
April 3rd 2020, 12:04pm
stocknewstimes @stocknewstimes
Arena Pharmaceuticals $ARNA Research Coverage Started at Guggenheim https://t.co/hB2Q0sB5eo
April 3rd 2020, 7:04am
EnterpriseLeade @EnterpriseLeade
Guggenheim Initiates Coverage on Arena Pharmaceuticals $ARNA https://t.co/iBadtv4E4Z
April 3rd 2020, 7:04am
ConsumerFeed @ConsumerFeed
Arena Pharmaceuticals $ARNA Research Coverage Started at Guggenheim https://t.co/nBXXAPnKD3
April 3rd 2020, 7:04am
BlueBioNow @BlueBioNow
$ARNA might be worth taking a position when this bottoms 2.71 % change recently https://t.co/i2vzthav1u
April 3rd 2020, 12:04am
OlympiaReport @OlympiaReport
Arena Pharmaceuticals $ARNA Research Coverage Started at Guggenheim https://t.co/K1XyKNj0zc
April 2nd 2020, 6:04pm
deus_trader @deus_trader
Optimus v4 2020-04-02 15:55 EST. *Closed/Sold: $ARNA at $43.66 for 1.60 profit (3.80%). Arena Pharmaceuticals, Inc… https://t.co/EBUBfiq1zL
April 2nd 2020, 4:04pm
semodough @semodough
$ARNA released top-line results from a ph1 trial evaluating a controlled-release (CR) delivery form of etrasimod. s… https://t.co/43LCY3QOms
April 2nd 2020, 3:04pm
Tickeron @Tickeron
$ARNA's in Uptrend: Moving Average Convergence Divergence (MACD) Histogram just turned positive. View odds for this… https://t.co/WUKAL8eu8o
April 2nd 2020, 12:04pm
gregorypozo @gregorypozo
RT @OpenOutcrier: $ARNA (-0.3% pre) Arena Pharmaceuticals Announces Positive Topline Data for New Development Program - Etrasimod Controlle…
April 2nd 2020, 8:04am
OpenOutcrier @OpenOutcrier
$ARNA (-0.3% pre) Arena Pharmaceuticals Announces Positive Topline Data for New Development Program - Etrasimod Con… https://t.co/LaIJId8T2U
April 2nd 2020, 8:04am
HealthcareBeat @HealthcareBeat
Arena Pharma announces encouraging data on controlled-release etrasimod $ARNA https://t.co/AgTIZ0UHC5
April 2nd 2020, 4:04am
Briefingcom @Briefingcom
$ARNA: Arena Pharm announces positive topline data from a Phase 1 clinical study for etrasimod https://t.co/y5eYwOPkSx
April 1st 2020, 6:04pm
Gambiste1 @Gambiste1
RT @RMPerry88: $ARNA out with “encouraging” data. Can’t decide just yet if that’s worse than “positive”. ?
April 1st 2020, 5:04pm
Gambiste1 @Gambiste1
RT @Biohazard3737: When was the last time a company held a conference call to discuss PK data for an extended release formulation? $ARNA
April 1st 2020, 5:04pm
Gambiste1 @Gambiste1
RT @Amp_Trades: $ARNA Arena Pharmaceuticals Announces Positive Topline Data for New Development Program - Etrasimod Controlled-Release (CR)
April 1st 2020, 5:04pm
RMPerry88 @RMPerry88
$ARNA out with “encouraging” data. Can’t decide just yet if that’s worse than “positive”. ?
April 1st 2020, 5:04pm
Biohazard3737 @Biohazard3737
When was the last time a company held a conference call to discuss PK data for an extended release formulation? $ARNA
April 1st 2020, 4:04pm
path1finder @path1finder
$ARNA https://t.co/Norh7lETKm
April 1st 2020, 4:04pm
otcdynamics @otcdynamics
$ARNA Arena Pharmaceuticals Announces Positive Topline Data for New Development Program – Etrasimod C https://t.co/uGFVnRSpdg
April 1st 2020, 4:04pm
Stock_News_Now @Stock_News_Now
$ARNA: New SEC Filing for ARNA: Form 8-K (No. 0001564590-20-014775): https://t.co/fg9H174Y9W
April 1st 2020, 4:04pm
MarketCurrents @MarketCurrents
$ARNA - Arena Pharma announces encouraging data on controlled-release etrasimod https://t.co/6Nh2hAFOBC
April 1st 2020, 4:04pm
fintel_io @fintel_io
Also, if you are new to $ARNA here's a background article on Finpedia for you https://t.co/ji7KyJC7bB
April 1st 2020, 4:04pm
fintel_io @fintel_io
$ARNA / Arena Pharmaceuticals files form 8-K - Regulation FD Disclosure, Financial Statements and Exhibits, Other E… https://t.co/Obzp7s4NcY
April 1st 2020, 4:04pm
VisualStockRSRC @VisualStockRSRC
$ARNA - Arena Pharmaceuticals Announces Positive Topline Data for New Development Program - Etrasimod https://t.co/0F9eeRkMDR
April 1st 2020, 4:04pm
Amp_Trades @Amp_Trades
$ARNA Arena Pharmaceuticals Announces Positive Topline Data for New Development Program - Etrasimod Controlled-Release (CR)
April 1st 2020, 4:04pm
Tickeron @Tickeron
$ARNA's in Uptrend: Moving Average Convergence Divergence (MACD) Histogram crosses above signal line. View odds for… https://t.co/sfEAEOfHnM
April 1st 2020, 3:04pm
Tickeron @Tickeron
$ARNA's in Uptrend: Moving Average Convergence Divergence (MACD) Histogram just turned positive. View odds for this… https://t.co/PA2fiq6QG2
March 31st 2020, 1:03pm
biostockinfo @biostockinfo
RT @TomSilver39: Guggenheim:" $ARNA - Modulating GPCRs to Treat Inflammation and Pain From the GI to the Skin; Initiate with a BUY Rating a…
March 31st 2020, 1:03pm
TomSilver39 @TomSilver39
Guggenheim:" $ARNA - Modulating GPCRs to Treat Inflammation and Pain From the GI to the Skin; Initiate with a BUY Rating and $95 PT."
March 31st 2020, 1:03pm
eat2muchfood @eat2muchfood
$ARNA Guggenheim Securities Initiates Coverage On Arena Pharmaceuticals with Buy Rating, Announces Price Target to $95
March 31st 2020, 12:03pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2020. All rights reserved.